Nephropathy of familial lecithin-cholesterol acyltransferase deficiency: report of a case.
Partial lecithin:cholesterol acyltransferase (LCAT) deficiency in Balkan endemic nephropathy.
IgG3κ Monoclonal Membranous Nephropathy Associated With Acquired Lecithin Cholesterol Acyltransferase Deficiency.
Novel therapeutic opportunities for familial lecithin:cholesterol acyltransferase deficiency: promises and challenges.
Vitali C, Rader DJ, Cuchel M.
Curr Opin Lipidol. 2023 Apr 1;34(2):35-43. doi: 10.1097/MOL.0000000000000864. Epub 2022 Dec 6.
IgG3kappa Monoclonal Membranous Nephropathy Associated With Acquired Lecithin Cholesterol Acyltransferase Deficiency.
Bu L, Lee JH, Quigley MM, Elahimehr R, Theis JD, Perrizo RL, Dasari S, Garrett TJ, Nasr SH.
Am J Kidney Dis. 2025 Sep 18:S0272-6386(25)01024-8. doi: 10.1053/j.ajkd.2025.06.021. Online ahead of print.
Two novel variants in the lecithin:cholesterol acyltransferase gene resulted in classic LCAT deficiency.
Fistrek Prlic M, Coric M, Calabresi L, Pavanello C, Mosca L, Cavallari U, Vukovic Brinar I, Karanovic S, Laganovic M, Jelakovic B.
Atheroscler Plus. 2022 Jun 2;49:28-31. doi: 10.1016/j.athplu.2022.05.005. eCollection 2022 Aug.
Acquired lecithin-cholesterol acyltransferase deficiency in nephrotic syndrome.
Vaziri ND, Liang K, Parks JS.
Am J Physiol Renal Physiol. 2001 May;280(5):F823-8. doi: 10.1152/ajprenal.2001.280.5.F823.
High-Density Lipoproteins and the Kidney.
Strazzella A, Ossoli A, Calabresi L.
Cells. 2021 Mar 31;10(4):764. doi: 10.3390/cells10040764.
Lecithin: cholesterol acyltransferase (LCAT) deficiency syndromes.
Frohlich J, McLeod R.
Adv Exp Med Biol. 1986;201:181-94. doi: 10.1007/978-1-4684-1262-8_16.
AJKD Atlas of Renal Pathology: Lecithin-Cholesterol Acyltransferase (LCAT) Deficiency.
Najafian B, Lusco MA, Finn LS, Alpers CE, Fogo AB.
Am J Kidney Dis. 2017 Jul;70(1):e5-e6. doi: 10.1053/j.ajkd.2017.05.003.
[Lecithin:Cholesterol Acyltransferase Deficiency, from genes to therapy].
Lucca F, Ossoli A, Boscutti G, Franceschini G, Calabresi L.
G Ital Nefrol. 2016 Malattie Metaboliche e Rene;33(S68):gin/33.S68.3.
Partial lecithin:cholesterol acyltransferase (LCAT) deficiency in Balkan endemic nephropathy.
Pavlović NM, Varghese Z, Persaud JW, Stefanović V, Strahinjić S, Savić V, Moorehead JF.
Kidney Int Suppl. 1991 Nov;34:S102-4.
Acquired lecithin:cholesterol acyltransferase deficiency as a major factor in lowering plasma HDL levels in chronic kidney disease.
Calabresi L, Simonelli S, Conca P, Busnach G, Cabibbe M, Gesualdo L, Gigante M, Penco S, Veglia F, Franceschini G.
J Intern Med. 2015 May;277(5):552-61. doi: 10.1111/joim.12290. Epub 2014 Aug 1.
